Can I legally tell patients I have Zepbound?

No. You should specify that you provide tirzepatide, the active ingredient in Zepbound, through your clinical partners.

Why is the private label approach better for patients?

It removes the uncertainty of pharmacy stock. Patients receive their medication directly from your clinic, ensuring they can stay on their prescribed schedule.

How do I start offering tirzepatide in my clinic?

You must apply for a wholesale account to verify your medical credentials and access our clinical platform.

GLP-1

When Patients Ask for Zepbound: Practical Steps for Clinics

Published July 8, 2026 · 4 minutes

Zepbound is now a household name. Patients see the results on social media and demand the specific brand. For a clinic owner, this creates a challenge. High demand meets low retail supply and narrow margins. You need a strategy to provide the active ingredient, tirzepatide, under your own clinical brand to ensure both patient satisfaction and business growth.

The Reality of Brand Requests

Patients often associate the brand name with safety and efficacy. When they ask for Zepbound, they are asking for tirzepatide. It is the active molecule that drives the metabolic changes they want. Your role is to educate them on the medication while explaining the logistics of clinical distribution.

Acknowledge the patient's research into tirzepatide.
Explain that Zepbound is a specific brand of that molecule.
Clarify current shortages in the retail pharmacy market.
Position your clinic as a direct source for medical-grade alternatives.

Maintaining Clinical Quality Control

Retail pharmacies are struggling to keep branded pens in stock. This inconsistency frustrates patients and disrupts their treatment cycles. By sourcing tirzepatide through a white-label platform, you control the inventory. This ensures your patients do not miss a dose due to national supply chain issues.

Use US-based facilities for sourcing.
Ensure every batch has a Certificate of Analysis.
Remove the middleman of the retail pharmacy.
Keep patient data and treatment history in-house.

Margins and Business Growth

Writing a prescription for a retail brand name provides zero profit for your clinic. You do the work of the consultation and the follow-up, but the pharmacy takes the revenue. Moving to a private label model changes the math. You capture the value of the medication and the clinical service together.

Educating Patients on Administration

The brand names use proprietary pens. When you provide tirzepatide directly, you must ensure the patient is comfortable with the administration method. This is an opportunity for a higher level of care and patient touchpoints.

Provide in-office injection training.
Explain the benefit of adjustable dosing.
Reduce the waste associated with single-use branded pens.
Improve patient compliance through direct oversight.

Legal and Ethical Communication

Never claim you are selling Zepbound if you are selling tirzepatide. Be clear about the distinction. Focus on the purity of the metabolite and the clinical standards of your facility. Transparency builds long-term trust and protects your medical license.

FAQs

Can I legally tell patients I have Zepbound?: No. You should specify that you provide tirzepatide, the active ingredient in Zepbound, through your clinical partners.
Why is the private label approach better for patients?: It removes the uncertainty of pharmacy stock. Patients receive their medication directly from your clinic, ensuring they can stay on their prescribed schedule.
How do I start offering tirzepatide in my clinic?: You must apply for a wholesale account to verify your medical credentials and access our clinical platform.

Launch your white-label program

Apply to Direct Peptide Sales, most practices onboard inside 30 days.

Apply now →